Haviland Kate - Insider Transactions
Insider Type
individual
Companies
1
Average
316,774
Total Txns
10
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 4 | -4 | 0.00 | 1,357,664.52 | -1,357,664.52 |
| 2025 | 0 | 6 | -6 | 0.00 | 1,810,076.56 | -1,810,076.56 |
| Total: | 0 | 10 | 10 | 0.00 | 3,167,741.08 | -3,167,741.08 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
86.14 USD |
598 Sold |
51,512 USD |
01/04/2025 | 01/04/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
87.34 USD |
1,200 Sold |
104,808 USD |
01/04/2025 | 01/04/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
88.59 USD |
100 Sold |
8,859 USD |
01/04/2025 | 01/04/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
85.47 USD |
600 Sold |
51,282 USD |
01/04/2025 | 01/04/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
88.80 USD |
16,151 Sold |
1,434,209 USD |
05/03/2025 | 05/03/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
110.24 USD |
1,446 Sold |
159,407 USD |
21/01/2025 | 21/01/2025 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
96.74 USD |
1,746 Sold |
168,908 USD |
29/11/2024 | 29/11/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
95.40 USD |
400 Sold |
38,160 USD |
29/11/2024 | 29/11/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
97.76 USD |
207 Sold |
20,236 USD |
29/11/2024 | 29/11/2024 |
| Blueprint Medicines Corporation Common Stock US09627Y1091 |
90.69 USD |
12,464 Sold |
1,130,360 USD |
07/03/2024 | 07/03/2024 |